Effectiveness and safety of coenzyme Q10 in people with heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis

STRENGTHS AND LIMITATIONS OF THIS STUDY

  • This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidance and followed a prospectively registered protocol.

  • No language restrictions were used, maximising identification of relevant primary studies.

  • Quantitative synthesis was not possible for many outcomes due to heterogeneity in intervention formulations, dosing regimens, cointerventions and outcome measures.

  • Introduction

    Heart failure is a chronic, progressive syndrome in which the heart is unable to pump enough blood to meet the body’s metabolic needs.1 The condition is characterised by key symptoms such as breathlessness, fatigue and reduced exercise tolerance.2 Globally, more than 64 million people are affected3 and the prevalence continues to rise alongside other common conditions such as hypertension, obesity and diabetes.4 The disease rarely follows a steady trajectory; it is characterised…
    This post was originally published on https://bmjopen.bmj.com